Health Care & Life Sciences » Pharmaceuticals | Sandu Pharmaceuticals Ltd.

Sandu Pharmaceuticals Ltd. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
8,232.00
6,287.00
6,529.00
10,142.00
-
-
Depreciation, Depletion & Amortization
5,360.00
10,524.00
6,931.00
7,217.00
-
-
Other Funds
4,439.00
1,416.00
2,075.00
13,056.00
-
-
Funds from Operations
9,153.00
15,395.00
11,385.00
30,415.00
11,639.00
-
Changes in Working Capital
29,063.00
19,638.00
40,832.00
6,281.00
-
-
Net Operating Cash Flow
19,910.00
35,033.00
29,447.00
36,696.00
-
-
Capital Expenditures
10,146.00
3,191.00
1,508.00
6,085.00
-
Purchase/Sale of Investments
141.00
-
9,747.00
2,329.00
-
Net Investing Cash Flow
8,248.00
3,028.00
778.00
8,414.00
-
Issuance/Reduction of Debt, Net
8,086.00
5,304.00
4,164.00
8,355.00
-
Net Financing Cash Flow
8,086.00
5,304.00
4,164.00
8,355.00
-
Net Change in Cash
20,072.00
26,701.00
34,389.00
19,927.00
-
Free Cash Flow
30,056.00
31,842.00
30,955.00
30,634.00
-
Other Sources
2,039.00
163.00
9,017.00
-
-

About Sandu Pharmaceuticals

View Profile
Address
Sandu Nagar
Mumbai Maharashtra 400071
India
Employees -
Website http://www.sandu.in
Updated 07/08/2019
Sandu Pharmaceuticals Ltd. manufactures and markets ayurvedic medicines. It offers specialty products including Berbenteron Pediatric Suspension, Berbenteron Compound Tablets, Bilagyl, Debix, Elegance Oil, Ephenin, Haemol Forte, Madiphal Rasayan, OSTEON-D, and others. The company was founded on May 10, 1899 and is headquartered in Mumbai, India .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.